Takeda Pharmaceutical Co. Ltd. - Cost of Goods Sold Including Depreciation and Amortization

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 1.96 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2023.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3801 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -26.39 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.3801 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -29.19 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.96 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -7.40 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.41 percent compared to the value the year prior.
The 1 year change in percent is -7.41.
The 3 year change in percent is 13.31.
The 5 year change in percent is 40.04.
The 10 year change in percent is 268.68.

The Serie's long term average value is 1.09 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 80.29 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +405.07%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -9.43%.